Anti-TIF1-Gamma-Positive Paraneoplastic Dermatomyositis Responsive to Immunotherapy with an Untreated Malignancy

被引：0
|
作者：
Jazebi, Noushin [1 ]
Solaiman, Ahmad Yusuf [1 ]
Shanina, Elena [1 ]
机构：
[1] UTMB, Galveston, TX USA
来源：
ANNALS OF NEUROLOGY | 2019年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
M267
引用
收藏
页码：S201 / S201
页数：1
相关论文
共 50 条
  • [21] Case report: Pneumatosis coli in an anti-TIF1-γ-positive dermatomyositis patient
    Ma, Ocean
    Day, Jessica
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (07)
  • [22] Anti-TIF1-γ-positive young adult dermatomyositis with germ cell tumour
    Etsuko Taki
    Makoto Shimizu
    Yuya Soeda
    Miyuki Shirai
    Yoshinao Muro
    European Journal of Dermatology, 2016, 26 : 623 - 624
  • [23] Cutaneous ulceration in dermatomyositis. Case reports with positive anti-NXP-2/anti-TIF1-gamma antibody status
    Wald, Caroline
    Simon, Jan-Christoph
    Treudler, Regina
    DERMATOLOGIE, 2025, 76 (02): : 97 - 100
  • [24] Amyopathic and anti-TIF1 gamma-positive dermatomyositis: analysis of a monocentric cohort and proposal to update diagnostic criteria
    Didona, Dario
    Juratli, Hazem A.
    Scarsella, Luca
    Keber, Ursula
    Eming, Ruediger
    Hertl, Michael
    EUROPEAN JOURNAL OF DERMATOLOGY, 2020, 30 (03) : 279 - 288
  • [25] Amyopathic and anti-TIF1 gamma-positive dermatomyositis: analysis of a monocentric cohort and proposal to update diagnostic criteria
    Dario Didona
    Hazem A. Juratli
    Luca Scarsella
    Ursula Keber
    Rüdiger Eming
    Michael Hertl
    European Journal of Dermatology, 2020, 30 : 279 - 288
  • [26] Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
    Nakanishi, Yu
    Yamaguchi, Kakuhiro
    Yoshida, Yusuke
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Masuda, Takeshi
    Nakashima, Taku
    Miyamoto, Shintarou
    Iwamoto, Hiroshi
    Hirata, Shintaro
    Fujitaka, Kazunori
    Hamada, Hironobu
    Sugiyama, Eiji
    Hattori, Noboru
    INTERNAL MEDICINE, 2020, 59 (20) : 2553 - 2558
  • [27] Erythrodermic dermatomyositis with anti-TIF1-γ antibodies
    Tang, Ke-yun
    Jin, Hong-zhong
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024, 63 (09) : 1274 - 1276
  • [28] The cancer immunotherapy environment may confound the utility of anti-TIF-1. in differentiating between paraneoplastic and treatmentrelated dermatomyositis. Report of a case and review of the literature
    Zarkavelis, George
    Mauri, Davide
    Karassa, Fotini
    Eleftherios, Kampletsas
    Pentheroudakis, George
    Pappadaki, Alexandra
    Mavroeidis, Leonidas
    Ntellas, Panagiotis
    Gkoura, Stefania
    Gazouli, Ioanna
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2020, 24 (01): : 75 - 78
  • [29] Clinical risk factors associated with malignancy in TIF1-γ(+) dermatomyositis
    Cassard, L.
    Flatley, E.
    Fernandez, A. P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S27 - S27
  • [30] Effectiveness of IVIG and balloon dilation combination therapy for refractory dysphagia in anti-TIF1-gamma antibody-positive dermatomyositis
    Utsunomiya, Akira
    Koizumi, Haruka
    Iino, Shiro
    Takashima, Wataru
    Tokuriki, Atsushi
    Tokunaga, Takahiro
    Kobayashi, Namiko
    Hamaguchi, Yasuhito
    Hasegawa, Minoru
    MODERN RHEUMATOLOGY CASE REPORTS, 2018, 2 (01) : 49 - 53
12345